Recognizing April 25th, 2026, As "diabetic Retinopathy Screening Day" In Delaware.
Summary
Senate Concurrent Resolution 176 recognizes April 25, 2026, as "Diabetic Retinopathy Screening Day" in Delaware. The resolution states that diabetes is a growing public health concern and that diabetic retinopathy is a common complication that can lead to preventable vision loss and blindness if not detected early. It highlights the importance of regular comprehensive eye exams, early diagnosis, and timely treatment, especially for people living with diabetes.
The resolution also commends the roles of the Delaware Academy of Ophthalmology and the Delaware Optometric Association in promoting eye health, expanding access to screening, and connecting patients to follow-up care. It notes that screening events are expected to be offered at participating hospitals, clinics, and community health centers across the state on the designated day, with the broader goal of improving awareness, reducing disparities, and preventing disability related to diabetic eye disease.
Impact
SCR176 does not change Delaware statutory law or create a regulatory program. Instead, it is a nonbinding concurrent resolution that formally designates a public awareness day and encourages Delawareans, particularly those with diabetes, to obtain regular eye screenings. Its practical effect is to support outreach efforts by health professionals and community partners and to reinforce existing public health and preventive care messaging around diabetic eye disease.
Sentiment
The available voting history suggests strong, bipartisan support for the resolution. The Senate third reading passed unanimously, 20-0, indicating broad agreement with the public health message and the symbolic recognition of the awareness day. No committee transcripts were provided, and there is no evidence of organized opposition in the materials supplied.
Contention
There is little apparent contention in the record. Because the measure is a ceremonial/public-awareness resolution rather than a policy or funding bill, it does not appear to raise disputes over mandates, costs, or regulatory changes. Any discussion implied by the text centers on public health priorities, access to screening, and the roles of ophthalmologists, optometrists, hospitals, and community health centers in improving early detection of diabetic retinopathy.